Catalyst Wire Dossier Catalyst Wire Dossier

EXXUA

GEPIRONE · Aytu Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EXXUA, covering 2023-09-22 to 2025-06-07. Get the full timeline:

Most recent: FDA Approved: EXXUA — Supplemental Application (Aytu Therapeutics, LLC)

See pricing